• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A 型肉毒毒素治疗紫外线诱导色素沉着的随机对照研究。

A Study of Botulinum Toxin A for Ultraviolet-Induced Hyperpigmentation: A Randomized Controlled Trial.

机构信息

All authors are affiliated with the Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Dermatol Surg. 2021 May 1;47(5):e174-e178. doi: 10.1097/DSS.0000000000002943.

DOI:10.1097/DSS.0000000000002943
PMID:33731570
Abstract

BACKGROUND

Ultraviolet (UV) exposure contributes to skin hyperpigmentation. Recently, botulinum neurotoxin type A (BoNT-A) showed a promising protective effect on UVB-induced hyperpigmentation in both in vitro and animal models.

OBJECTIVE

The study aimed to investigate the preventive effect of BoNT-A against UVB-induced hyperpigmentation in human subjects.

MATERIALS AND METHODS

A prospective, double-blinded, randomized controlled trial was performed in 15 healthy participants. Four separate square areas on the abdomen were randomly injected intradermally with different dilutions of BoNT-A (1:2.5, 1:5, 1:7.5) and normal saline (control). Two weeks after injection, hyperpigmented spots were induced by UVB irradiation at the experimental sites. The lightness index and hyperpigmentation scores from blinded physician and participants were evaluated.

RESULTS

Fifteen participants completed the study. One week after UVB irradiation, all BoNT-A-treated sites had a significantly lower degree of hyperpigmentation than the control site in lightness index and hyperpigmentation scores from blinded physician and participants (p < .05). However, no statistically significant difference was observed between different concentrations of BoNT-A. No side effects were observed throughout the study period.

CONCLUSION

Intradermal BoNT-A injection provided a protective effect from UVB-induced hyperpigmentation. It may be used for other hyperpigmentation disorders that are aggravated by UVB.

摘要

背景

紫外线(UV)暴露会导致皮肤色素沉着。最近,肉毒毒素 A 型(BoNT-A)在体外和动物模型中均显示出对 UVB 诱导的色素沉着具有有前景的保护作用。

目的

本研究旨在探讨 BoNT-A 对人体 UVB 诱导的色素沉着的预防作用。

材料和方法

对 15 名健康参与者进行了前瞻性、双盲、随机对照试验。将不同浓度的 BoNT-A(1:2.5、1:5、1:7.5)和生理盐水(对照)分别以皮内注射的方式随机注射到腹部的四个不同的正方形区域。注射两周后,在实验部位用 UVB 照射诱导色素沉着斑。由盲法医生和参与者评估亮度指数和色素沉着评分。

结果

15 名参与者完成了研究。在 UVB 照射后 1 周,所有 BoNT-A 治疗部位的亮度指数和盲法医生及参与者评估的色素沉着评分均明显低于对照部位(p<0.05)。然而,不同浓度的 BoNT-A 之间没有观察到统计学上的显著差异。整个研究期间未观察到任何副作用。

结论

皮内注射 BoNT-A 可提供对 UVB 诱导的色素沉着的保护作用。它可能用于其他因 UVB 加重的色素沉着障碍。

相似文献

1
A Study of Botulinum Toxin A for Ultraviolet-Induced Hyperpigmentation: A Randomized Controlled Trial.A 型肉毒毒素治疗紫外线诱导色素沉着的随机对照研究。
Dermatol Surg. 2021 May 1;47(5):e174-e178. doi: 10.1097/DSS.0000000000002943.
2
Study of botulinum toxin type A for the treatment of ultraviolet B-induced hyperpigmentation: A prospective, randomized, controlled trial.A型肉毒毒素治疗紫外线 B 诱导的色素沉着过度的研究:一项前瞻性、随机、对照试验。
J Cosmet Dermatol. 2022 Aug;21(8):3343-3350. doi: 10.1111/jocd.14966. Epub 2022 Apr 12.
3
Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial.A型肉毒毒素治疗紫外线 B 诱导的色素沉着过度:一项前瞻性、随机、对照试验。
Toxins (Basel). 2022 Jun 17;14(6):417. doi: 10.3390/toxins14060417.
4
UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study.紫外线B照射减弱A型肉毒杆菌毒素的皮肤效应:一项随机、双盲、安慰剂对照研究。
Dermatol Surg. 2007 Jan;33(1 Spec No.):S92-6. doi: 10.1111/j.1524-4725.2006.32338.x.
5
Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.不同剂量和稀释度的三种不同肉毒杆菌毒素制剂皮内注射时的疼痛感觉。
Dermatol Surg. 2006 Jul;32(7):886-90. doi: 10.1111/j.1524-4725.2006.32191.x.
6
Isobutylamido thiazolyl resorcinol for prevention of UVB-induced hyperpigmentation.异丁基酰胺基噻唑基间苯二酚用于预防紫外线B诱导的色素沉着过度。
J Cosmet Dermatol. 2021 Mar;20(3):987-992. doi: 10.1111/jocd.13615. Epub 2020 Aug 5.
7
Non-invasive high-intensity focused ultrasound for UV-induced hyperpigmentation in Fitzpatrick skin types III and IV: a prospective, randomized, controlled, evaluator-blinded trial.非侵入性高强度聚焦超声治疗 Fitzpatrick III 型和 IV 型皮肤的紫外线诱导色素沉着:一项前瞻性、随机、对照、评估者盲法试验。
Lasers Med Sci. 2018 Feb;33(2):361-367. doi: 10.1007/s10103-017-2393-5. Epub 2017 Nov 27.
8
Protective Effect of Botulinum Toxin against Ultraviolet-Induced Skin Pigmentation.肉毒毒素对紫外线诱导皮肤色素沉着的保护作用。
Plast Reconstr Surg. 2019 Aug;144(2):347-356. doi: 10.1097/PRS.0000000000005838.
9
Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.脑卒后 12 周内上肢痉挛患者接受肉毒毒素注射治疗的随机对照试验。
Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27.
10
Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study.早期肉毒杆菌毒素治疗痉挛性马蹄内翻足——一项随机双盲安慰剂对照研究。
Eur J Neurol. 2014 Aug;21(8):1089-1095. doi: 10.1111/ene.12381. Epub 2014 Feb 12.

引用本文的文献

1
Efficacy of Botulinum Toxin A for the Management of Melasma: A Split-Face, Randomized Control Study.A型肉毒毒素治疗黄褐斑的疗效:一项半脸随机对照研究。
J Cosmet Dermatol. 2025 Aug;24(8):e70376. doi: 10.1111/jocd.70376.
2
Efficacy and Safety of Letibotulinum Toxin A for the Treatment of Melasma in Two Different Dilutions: A Randomized Double-Blind Split-Face Study.两种不同稀释度的利妥昔单抗治疗黄褐斑的疗效和安全性:一项随机双盲半脸研究。
Toxins (Basel). 2025 Jul 11;17(7):349. doi: 10.3390/toxins17070349.
3
Insights on Skin Quality and Clinical Practice Trends in Asia Pacific and a Practical Guide to Good Skin Quality from the Inside Out.
亚太地区皮肤质量洞察与临床实践趋势以及由内而外的良好皮肤质量实用指南。
J Clin Aesthet Dermatol. 2022 Jun;15(6):10-21.
4
Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial.A型肉毒毒素治疗紫外线 B 诱导的色素沉着过度:一项前瞻性、随机、对照试验。
Toxins (Basel). 2022 Jun 17;14(6):417. doi: 10.3390/toxins14060417.